Do cerebral microbleeds increase the risk of dementia? A systematic review and meta-analysis

Ahmed Salah Hussein1,2, Muhammad Shawqi1,3, Eshak I Bahbah1,4

  • 1Medical Research Group of Egypt (MRGE), Cairo, Egypt.

IBRO Neuroscience Reports
|January 12, 2023
PubMed
Abstract

Insights

Cerebral microbleeds (CMBs) significantly double the risk of developing dementia. Early detection of CMBs aids in identifying at-risk individuals for timely intervention and management.

Area of Science:

  • Neurology
  • Geriatrics
  • Vascular Medicine

Background:

  • Dementia is a prevalent neurological disorder in the elderly.
  • Cerebral microbleeds (CMBs), small vascular lesions, are a potential risk factor for dementia.
  • Existing data on the CMBs-dementia association is inconsistent.

Purpose of the Study:

  • To systematically review and meta-analyze the association between CMBs and dementia risk.
  • To explore potential explanations for the observed associations.

Main Methods:

  • Systematic review and meta-analysis following PRISMA and Cochrane guidelines.
  • Searched electronic databases, screened articles, extracted data, and appraised quality (Newcastle-Ottawa Scale).
  • Pooled data using random-effects meta-analysis (Review Manager software).

Main Results:

  • Included 9 studies with 14,221 participants (>18 months follow-up).
  • CMBs significantly increased dementia risk (RR 1.84, 95% CI [1.27-2.65]).
  • Significant associations found in high-risk and general populations, but not memory clinic patients; CMBs increased progression to dementia over time (HR 2, 95% CI [1.54-2.61]).

Conclusions:

  • Individuals with CMBs have a twofold increased risk of dementia or mild cognitive impairment (MCI).
  • CMB detection identifies individuals at higher risk for dementia.
  • Recommendations include patient/family education, regular cognitive assessments, cognitive training, lifestyle modifications, and managing risk factors.